Health Catalyst Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $292.2M-4.7% YoYTTM through 30 Jun 2026
Net Income -$264.8MTTM through 30 Jun 2026
Free Cash Flow $27MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 38.7% |
| EBITDA Margin | -67.7% |
| Operating Margin | -51.7% |
| Net Margin | -90.6% |
Returns
-72.4%ROE
-73.8%ROA
Balance Sheet Health
Debt / Equity0.62x
Current Ratio1.89x
Net Debt$65M
Cash & Equivalents$60.6M
Quality Metrics
Altman Z-Score-6.52
Piotroski F-Score4 / 9
FCF Margin9.2%
Earnings-Beat Rate50.0%
Multi-Year Trend
RevenueFY2025: $311.1M
Diluted EPS-$3.68TTMFY2025: $-2.55
Dividend
No dividend
Capital Allocation
R&D Spend$43M
Capex Intensity0.4%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Technology | |||
| Professional Services |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.